News

Saint Luke's Rehabilitation Institute's newest staff member is making an immediate impact on patient care this year. Henli is a two-year old facility dog, highly trained to work in clinical settings alongside licensed therapists.

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

Two years after an intern presented on the clinical and emotional benefits of service animals, the Rehabilitation Institute is delighted to introduce the world to Henli, a highly trained dog with a knack for comfort and connection.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

Reconnecting with a former high school classmate turned out to be a saving grace in Lori’s life.